EIF2AK4 and plasma cell myeloma: We in turn show that inhibition of GCN2 has anti-myeloma activity in a panel of HMCLs, consistent with previous studies that show GCN2 to be critical for cancer cell survival in solid tumours under conditions of nutrient deprivation44,56.